Where are you?
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Singapore
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.

Liontrust GF High Yield Bond Fund

Q3 2021 review

Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested.

The Fund (C5 sterling accumulation class) returned 0.8%* in sterling terms in Q3 2021 while the ICE Bank of America Merrill Lynch Global High Yield Index (GBP hedged) comparator benchmark returned 0.2% and the average return for the IA Sterling High Yield reference sector was 0.7%. The primary B5 US dollar share class returned 0.8% while the ICE Bank of America Merrill Lynch Global High Yield Index (USD hedged) comparator benchmark returned 0.2% and the average return for the EAA Fund USD High Yield Bond (Morningstar) reference sector was -3.2%.

 

We also compare the Fund’s performance to a leading Global High Yield ETF (seeking to outperform by 1.5% a year). The Fund’s C5 sterling shares class return was slightly ahead of the ETF in Q3 and has now outperformed it by around five percentage points since inception (June 2018).

 

The Market

 

We would use the word ‘resilient’ to describe the high yield market in Q3. Resilient in the face of the equity market volatility we’ve seen towards the end of the quarter, and resilient in the face of rising government bond yields. As we’ve mentioned in previous reports, some of the resilience being shown by the lower-quality end of the market is indeed down to the spectre of inflation and rising government bond yields, with many seeing CCCs as a ‘haven’ if you’re worried about duration risk.

 

The global market produced a return of 0.2%; however, the global index includes Chinese real estate, where there are well publicised issues. US CCCs returned 1.0% and EUR CCCs 1.5%. Similarly, US and Euro Bs were resilient, returning 0.7% and 1.0%, respectively. US BBs returned 1.1% and European 0.7%.

 

The Fund

 

There were very few bonds that contributed or detracted any more than a few basis points during the quarter. The best performing holding was a capital providing bond issued by agricultural co-op bank, Rabobank. This was mainly driven by a leading investment bank publishing a positive view on what is something of a niche bond. The note clearly put the bond on the radar of a few more investors and the price jumped around 5%.

 

Bonds issued by Altice International, a telecom company generating the vast majority of its revenues in Portugal, have been a modest drag on performance. We own 2028 and 2029 maturity, euro denominated bonds, which are longer duration than average. We find Altice an interesting opportunity as, in our view, the bonds seem to be a tool for investment banks to ‘play’ periods of modest volatility, like we have seen around the turn of Q4. Whenever there is a slight turn in sentiment, one of the first comments you see from investment bank dealers is “calling Altice bonds lower”. This is technical rather than fundamental and if we were to see sustained, material volatility, other bonds would soon catch up. In the meantime, because of these technicals, Altice trades at a perennial discount, i.e., higher yield than would be suggested by the stability of telecom assets and indeed its credit rating. Rather than trade in and out of Altice on sentiment (and boost trading desk commissions), we are happy to accept this volatility in an average sized position and earn the extra yield that comes with the bond over the long term.

 

On an index relative basis, not owning anything related to the Chinese real estate sector was a strong contributor to performance. During a quarter when individual bond returns were in a tight range, two new holdings from the German real estate sector were detractors. We have taken a small position in bonds issued by Adler Real Estate, an operating subsidiary within Adler Group. There are various issues faced by Adler Group including political risks and, indeed, its own financial transparency. On the latter, prior to our investment the company had improved disclosure. We purchased bonds at a price of around 92.5, with the bonds having traded as high as 105 as recently as June. Ultimately, we believe Adler has enough asset value to navigate the current stormy waters. Towards the end of the quarter, on no additional news, the bonds dropped a further 6-7% - hence the cost to Fund returns. In the early days of October, the bonds have moved back closer to our average entry level.

 

The other new real estate holding is a company called Vivion which owns office assets in Germany and hotel assets in UK. It has been dragged down by general sentiment towards real estate rather than any fundamental issues specific to its credit worthiness.

 

During the quarter, portfolio activity has been relatively modest. We took small holdings in a couple of investment grade bonds, both of which offer BB-type spread. The first was a hybrid bond issued by US utility Southern at a spread close to 2.5%. The second was an investment company (structured as a trust) called Pershing Square at a spread close to 2.0%.

 

As mentioned, we purchased two German real estate holdings. In addition, we purchased bonds issued by an office-focussed Swedish real estate offering a spread of almost 4%. Note that we reduced holdings in CPI Property, a Czech/German real estate company and completely exited from the holding in Aroundtown Property.

 

Lastly, we purchased a US-based medical equipment distributor called AdaptHealth. We view the main risks in this sector as pricing pressure and risks around who’s paying (no national health service); we believe these are mitigated by AdaptHealth’s diversity. We purchased these bonds with a yield of 5.125%, when the market in general had a yield of around 4.25%.

 

Since the start of the year, to hedge the risk of rising rates – to the extent there is interest rate risk (or duration) in the high yield market – we’ve managed the Fund with some hedges in place. In Q3, these hedges contributed around 0.17% to Fund performance.

 

Outlook

 

Back to resilience. Due to our expectations for very low underlying defaults, we think the Fund’s current yield is a reliable guide to returns for the medium to long-long term investor. However, the path returns will take is obviously unpredictable. If rates continue to rise, it feels as if the equity market could see further declines as analysts start to use higher discount rates in their models and investors in general come to terms with less central bank manipulation of asset prices. In our view, such volatility would impact high yield bonds, but to a much smaller degree than equities.

We continue to mainly avoid the lower-quality parts of the market. As we’ve said before, we view the notion of CCCs being a haven in any market environment as fundamentally flawed. There is little upside and the reward of merely potentially outperforming more duration-exposed bonds is not enough to mitigate the risks of investing in an area where economic shocks can be so damaging. You’d be better off in equities. We’re sticking with higher-quality high yield, where we think the overall investment proposition remains relatively attractive.

Meanwhile, we continue to run with a short duration compared to the high yield index and we continue to run with a limited exposure to longer-dated bonds.

Discrete 12 month performance to last quarter end (%)**:

 

Sep-21

Sep-20

Sep-19

Liontrust GF High Yield Bond C Acc GBP

10.0%

0.4%

6.6%

ICE BofAML Global High Yield Hedge USD

9.8%

1.3%

5.4%

IA Sterling High Yield

10.6%

-0.4%

4.7%

 

Discrete data is not available for five full 12 month periods due to the launch date of the portfolio.

 

Fund positioning data sources: UBS Delta, Liontrust.

 

*Source: Financial Express, as at 30.09.21, total return (net of fees and interest reinvested).

 

**Source: Financial Express, C5 share class, total return, net of fees and interest reinvested. As at 30.09.21. The primary share class for this Fund is in US dollars (B5) but we are showing the C sterling-hedged class to compare against the IA Sterling High Yield sector.

While the managers of the Fund seek to outperform a leading Global High Yield ETF by 1.5% a year net of fees over rolling three years, this is not a formal objective. There can be no guarantees this will be achieved over the stated time period. The formal objective of the Fund can be found in the Prospectus.

Understand common financial words and terms See our glossary
KEY RISKS

Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested.
The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in Funds managed by the Global Fixed Income team involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. The Funds may invest in emerging markets/soft currencies which may have the effect of increasing volatility. Some of the Funds may invest in derivatives. The use of derivatives may create leverage or gearing. A relatively small movement in the value of a derivative's underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead.

DISCLAIMER

This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.

This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust. Always research your own investments and if you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.

Related commentaries

See all related

How to invest in Liontrust funds

Through a fund platform
Through a financial adviser
Direct with Liontrust